Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

TP protocol 2pembrolizumab 1cabozantinib 1Technetium 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Radiotherapy 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Indocyanine Green 1Control Groups 1Cobalt-60 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphatic Metastasis × Control Groups × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡